Turkey has been watching closely, not out of solidarity or rivalry, but recognition. Ankara is undergoing a parallel test, ...
The Daily Overview on MSNOpinion
350 US meds get pricier as drugmakers push ahead anyway
Drug companies are starting 2026 by lifting list prices on a huge slate of brand name medicines, even as the White House and ...
From a security perspective, the transition from 2025 to 2026 shows that risks in Türkiye’s immediate neighborhood have taken ...
Morning Overview on MSN
New model hints Alzheimer’s could be rolled back, not just slowed
For more than 100 years, Alzheimer’s disease has been treated as a one‑way descent, a diagnosis that could be delayed at best ...
Sionna Therapeutics raised about $191 million in its initial public offering last February. Since then it's made progress with experimental treatments for cystic fibrosis. In June, the company ...
In 2026, here's what you can expect from the AI industry: new architectures, smaller models, world models, reliable agents, ...
You can avoid that kind of thing if you don’t go looking for it. The truth is, the Racist Murder Pit is the best place to ...
Discover why Microsoft is a top buy with strong AI-driven growth, rising Azure revenue, and 113% price upside.
Trump mentioned the first U.S. strike on Venezuelan soil in a radio interview as if it wasn't even important news.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Balancing electronic and ionic charge carriers in polymer nanofilms significantly improves physical reservoir computing, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results